SHOULDER INNOVATIONS, INC. Debt Securities, Available-for-sale, Realized Gain (Loss)
SHOULDER INNOVATIONS, INC. (SI) reported Debt Securities, Available-for-sale, Realized Gain (Loss) of -$40.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2026-06-30 was -$201.00K, a 546.67% decline year-over-year.
- SHOULDER INNOVATIONS, INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2026-03-31 was $161.00K, a 0.62% decline year-over-year.
- SHOULDER INNOVATIONS, INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2025-12-31 was $2.00K, a 99.34% decline year-over-year.
- SHOULDER INNOVATIONS, INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2025-09-30 was $195.00K, a 47.73% increase year-over-year.
- SHOULDER INNOVATIONS, INC. debt securities, available-for-sale, realized gain (loss) for fiscal 2025 was $404.00K, a 16.18% decline from fiscal 2024.
- SHOULDER INNOVATIONS, INC. debt securities, available-for-sale, realized gain (loss) for fiscal 2024 was $482.00K.
| Period end | Debt Securities, Available-for-sale, Realized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 9 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$201.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$40.00K 10-Q · filed 2026-08-06 | -$38.00K derived: sum of 3 quarters · filed 2026-08-06 | $157.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $161.00K 10-Q · filed 2026-05-13 | $163.00K derived: sum of 2 quarters · filed 2026-05-13 | $358.00K derived: sum of 3 quarters · filed 2026-05-13 | $403.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $197.00K derived: sum of 2 quarters · filed 2026-03-10 | $242.00K derived: sum of 3 quarters · filed 2026-08-06 | $404.00K 10-K · filed 2026-03-10 |
| 2025-09-30 | $195.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $240.00K derived: sum of 2 quarters · filed 2026-08-06 | $402.00K 10-Q · filed 2025-11-12 | $703.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $207.00K 10-Q · filed 2026-08-06 | $508.00K derived: sum of 3 quarters · filed 2026-08-06 | $640.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $162.00K 10-Q · filed 2026-05-13 | $463.00K derived: sum of 2 quarters · filed 2026-05-13 | $595.00K derived: sum of 3 quarters · filed 2026-05-13 | |
| 2024-12-31 | $301.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $433.00K derived: sum of 2 quarters · filed 2026-03-10 | $482.00K 10-K · filed 2026-03-10 | |
| 2024-09-30 | $132.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $181.00K 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $49.00K 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |